¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"mixed base crude oil"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • acid-base compensation
    »ê¿°±âº¸»ó
  • acid-base equilibrium
    »ê¿°±âÆòÇü
  • acid-base indicator
    »ê¿°±âÁö½Ã°è
  • alveolar base
    ÀÌÆ²¹Ù´Ú, Ä¡Á¶±âÀú
  • base
    1. ¹Ù´Ú, ¹ÙÅÁ, ±âÀú 2. ¾ËÄ®¸®, ¿°±â 3. ±âÁ¦
  • base curve
    ±âº»°î¼±
  • base deficit
    ¿°±â°áÇÌ
  • base excess
    ¿°±â°úÀ×
  • base exchange
    ¿°±â±³È¯
  • base of heart
    ½ÉÀå¹Ù´Ú, ½ÉÀåÀúºÎ
  • base of skull
    ¸Ó¸®»À¹Ù´Ú, µÎ°³Àú
  • base pair
    ¿°±â½Ö
  • base pair substitution
    ¿°±â½Öġȯ
  • base pairing
    ¿°±â¦Áþ±â
  • base unit
    ±âº»´ÜÀ§
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • base of skull
    ¸Ó¸®»À¹Ù´Ú, µÎ°³Àú
  • base curve
    ±âº»°î¼±
  • base excess
    ¿°±â°úÀ×
  • base exchange
    ¿°±âġȯ
  • base line
    ¹ÙÅÁ¼±, ±âÁؼ±
  • base pair
    ¿°±â½Ö
  • base pairing
    ¿°±â¦Áþ±â
  • base line shift
    ±âÁؼ±À̵¿
  • base pair substitution
    ¿°±â½Ö´ëÄ¡
  • buffer base
    ¿ÏÃæ¿°±â
  • conjugate base
    ¦¿°±â
  • monoacidic base
    Àϻ꿰±â
  • ointment base
    ¿¬°í±âÁ¦
  • purine base
    Ç»¸°¿°±â
  • vitreous base
    À¯¸®Ã¼¹Ù´Ú, À¯¸®Ã¼±âÀú
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • apricot kernel oil
    ÇàÀÎÀ¯(úºìÒêú).
  • aromatic castor oil
    ¹æÇ⼺ ¾ÆÁֱ±â¸§.
  • gaultheria oil
    µ¿·ÏÀ¯(ÔÏÖàêú).
  • halibut liver oil
    °¡Àڹ̰£À¯(¡­ÊÜêú).
  • hardened oil
    °æÈ­À¯(Ìãûùêú).
  • hardening oil
    °æÈ­À¯(Ìãûùêú).
  • heavy oil
    ÁßÀ¯(ñìêú).
  • hydrocarpous oil
    ´ëdzÀÚÀ¯(ÓÞù¦í­êú).
  • immersion oil
    ħÁöÀ¯(öÙò°êú).
  • immersion oil
    À¯Ä§À¯
  • immersion oil
    À¯Ä§À¯
  • immersion oil
    ´äÁóÀ¯.
  • poppy oil
    ¾ç±ÍºñÀ¯(¡­êú).
  • poppy sead oil
    ¾ç±Íºñ¾¾À¯.
  • rectiled turpentine oil
    Á¤Á¦Å׸£ÆæÀ¯ (ïñ𲡭êú).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • base excess
    ¿°±â °úÀ×(Φí¥)
  • base excess =BE
    ¿°±â°úÀ×(ç¤ÐñΦ í¥).
  • base excess/deficit
    ¿°±â°úÀ×/°áÇÌ
  • base exchange
    ¿°±âġȯ(¡­öÇüµ).
  • base line
    ±âÁؼ±
  • base line
    ±â¼±(ÐñàÊ). ±â(Àú)¼±, ¹ÙÅÁ¼±.
  • base line data
    ±âÃÊÀÚ·á.
  • base line shift
    ±âÁؼ± À̵¿ (ÐññÞàÊ ì¹ÔÑ)
  • base line shift
    ±âÁؼ± º¯À§
  • base metal
    õ±Ý¼Ó(ôÁÐÝáÕ).
  • base metal alloy
    ºñ±Ý¼ÓÇÕ±Ý(ÞªÐÝáÕùê ÐÝ).
  • base of cell
    ¼¼Æ÷¹Ù´Ú
  • base of cochlea
    ´ÞÆØÀ̹ٴÚ
  • base of column
    ±âµÕ¹Ù´Ú
  • base of hair follicle
    ÅÐÁָӴϹٴÚ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • base analogue
    ¿°±âÀ¯»ç¹°(ç¤Ðñ×¾ÞÄÚª)
  • base composition
    ¿°±â Á¶¼º(ç¤Ðñ ðÚà÷)
  • base excision repair
    ¿°±â ÀýÁ¦¼ö¼±(ç¤Ðñ ï·ð¶áóàË)
  • base line
    ¹Ù´Ú ¼±(àÊ)
  • base pair
    1. ¿°±â ¦ 2. ¿°±â ½Ö(äª)
  • base pair
    (Ó¤êÈ) base pair
  • base pairing
    "¿°±â(ç¤Ðñ) ¦Áþ±â, ¿°±â ¦Áö¿ò"
  • base-pairing rules
    ¿°±â ¦Áþ±â ±ÔÄ¢(ЮöÎ)
  • base-pair ratio
    ¿°±â¦ ºñ(Ýï)
  • base-pair substitution
    ¿°±â¦ ġȯ(öÇüµ)
  • base ratio
    ¿°±âºñ(ç¤ÐñÝï)
  • base sequence
    ¿°±â¼­¿­(ç¤ÐñßíÖª)
  • base specificity
    ¿°±âƯÀ̼º(ç¤Ðñ÷åì¶àõ)
  • base stacking
    ¿°±â(ç¤Ðñ) ½×ÀÓ
  • base substitution
    ¿°±âġȯ(ç¤ÐñöÇüµ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
CP candle power; capillary pressure; cardiac pacing; cardiac performance; cardiopulmonary; caudate puta...
TACE chlorotrianicene; teichoic acid crude extract
CLO cod liver oil
CO carbon monoxide; cardiac output; castor oil; casualty officer; centric occlusion; cervical orthosis;...
EPO eosinophil peroxidase; erythropoiesis; erythropoietin; evening primrose-oil; exclusive provider orga...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
BER Base Excision Repair
BD Base deficit
BL Base-line
DB Data Base
DBMS Data Base Management System
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • mixed dental arch
    È¥ÇÕ Ä¡¿­±Ã
  • mixed dentition analysis
    È¥ÇÕ Ä¡¿­±âÀÇ ¾Ç±Ã °ø°£ ºÐ¼®
    È¥ÇÕ Ä¡¿­±â ±³ÇÕÀº ¿µ±¸ Á¦1 ´ë±¸Ä¡°¡ ¸ÍÃâÇÏ´Â 6-7¼¼ºÎÅÍ Çü¼ºµÈ´Ù. ½ÃÁø ¹× ±¸°­ ¹æ»ç¼±ÇÐÀû °Ë»çÀÇ È°¿ëÀ» ÅëÇØ ¿µ±¸Ä¡ ¸ÍÃâ ¼ø¼­¸¦ »ìÆìº¸´Â °ÍÀº Á¤»ó ±³ÇÕ Çü¼ºÀÇ °¡´É¼º ÆÇ´Ü¿¡ À¯È¿ÇÑ Á¤º¸¸¦ Á¦°øÇØ ÁØ´Ù.
  • mixed echo
    È¥ÇÕ ¿¡ÄÚ, È¥ÇÕ ¸Þ¾Æ¸®
  • mixed form
    È¥ÇÕ Çü
  • mixed function oxidase
    È¥ÇÕ ±â´É ¿Á½Ãµ¥À̽º
  • mixed germ cell tumors
    È¥ÇÕ ¹è¾Æ¼¼Æ÷ Á¾¾ç
  • mixed headache
    È¥ÇÕÇü µÎÅë
    ±Ù ±äÀ强 µÎÅë°ú ÆíµÎÅëÀÌ ÇÑ È¯ÀÚ¿¡¼­ ÇÔ²² ³ªÅ¸³¯ ¶§.
  • mixed lymphocyte culture
    È¥ÇÕ ¸²ÇÁ±¸ ¹è¾ç
  • mixed mesodermal tumor
    È¥ÇÕ Á߹迱¼º Á¾¾ç, È¥ÇÕ¼º Á߹迱¼º Á¾¾ç
  • mixed muscular vascular headache
    ±Ù¸Æ°ü¼º È¥ÇÕ µÎÅë, È¥ÇÕµÈ ±Ù-Ç÷°ü¼º µÎÅë, È¥ÇÕ¼º ±ÙÀ° Ç÷°ü µÎÅë, È¥ÇÕÇü ±Ù¸Æ°ü¼º µÎÅë
  • mixed odontogenic tumor
    È¥ÇÕ Ä¡¼º Á¾¾ç
  • mixed paralysis
    È¥ÇÕ ¸¶ºñ
    ¿îµ¿°ú °¨°¢ÀÇ ¿¬ÇÕ ¸¶ºñ.
  • mixed race
    È¥Ç÷ ÀÎÁ¾
  • mixed salivary gland
    º¹ÇÕ Ä§»ù, È¥ÇÕ Å¸¾×¼±
  • mixed small and large cell lymphoma
    È¥ÇÕ¼º ´ë¼Ò¼¼Æ÷ ¸²ÇÁÁ¾
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
mixed infection Infection by more than one variety of pathogenic microorganisms.
(05 Mar 2000)
mixed lymphocyte culture <investigation> Test to determine whether a patients and donor's white blood cells interact adversely. Often used to determine whether a person would be a suitable bone marrow donor for a particular patient.
(16 Dec 1997)
mixed lymphocyte culture test Measure of histocompatibility at the hl-a locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (measured by tritiated thymidine uptake) whereas those from compatible individuals will not. In the one-way mlc test, the lymphocytes from one of the individuals are inactivated (usually by treatment with mitomycin c or radiation) thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens.
(12 Dec 1998)
mixed lymphocyte reaction <haematology, immunology, investigation> Reaction of mitogenesis produced in T lymphocytes when allogeneic (i.e. Mixed) lymphocytes are brought together, provided they are mismatched in histocompatibility loci. Once used as a test for possible graft compatibility in human grafting. Now known that a negative reaction is a poor predictor of graft acceptance.
(18 Nov 1997)
mixed mesodermal tumour A sarcoma of the body of the uterus arising in older women, composed of more than one mesenchymal tissue, especially including striated muscle cells.
Synonym: malignant mixed mullerian tumour.
(05 Mar 2000)
mixed nerve <anatomy, nerve> A nerve containing both afferent and efferent fibres.
(05 Mar 2000)
mixed opioid agonist-antagonist <pharmacology> A compound that has an affinity for two or more types of opioid receptors and blocks opioid effects on one receptor type while producing opioid effects on a second receptor type.
(13 Nov 1997)
mixed paralysis Combined motor and sensory paralysis.
(05 Mar 2000)
mixed sleep apnoea <chest medicine> A form of sleep apnoea where there is exists a combination of obstructive and central sleep apnoea syndromes.
(13 Nov 1997)
mixed thrombus A laminated thrombus, the layers of different ages being of different colour or consistency.
Synonym: stratified thrombus.
(05 Mar 2000)
mixed tide <ecology, marine biology> Tidal cycle in which there are usually two high and two low tides during a day.
(13 Nov 1997)
mixed tumour A tumour composed of two or more varieties of tissue.
(05 Mar 2000)
mixed tumour, malignant A malignant tumour composed of more than one type of neoplastic tissue.
(12 Dec 1998)
mixed tumour, mesodermal A sarcoma of the body of the uterus arising in older women, composed of more than one mesenchymal tissue, especially including striated muscle cells. It is associated with previous pelvic radiation exposure in 20% of patients.
(12 Dec 1998)
mixed tumour, mullerian A tumour, basically a carcinoma with a single sarcoma such as leiomyosarcoma or angiosarcoma or multiple sarcomas of uterine origin. The role of oestrogen has been postulated as a possible aetiological factor in this tumour. (holland et al., cancer medicine, 3d ed, p1703)
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • base
    ±âÃÊ;±â½¾;±âÁö;Ãâ¹ßÁ¡;õÇÑ;ºñ¿­ÇÑ-±âÃʸ¦ µÎ´Ù(on)
  • base exchange
    ¸ÅÁ¡
  • base hit
    ¾ÈŸ
  • base line
    ±âÁؼ±;´©¼±
  • base metal
    ºñ±Ý¼Ó
  • base runner
    ÁÖÀÚ
  • base running
    ÁÖ·ç
  • base stealing
    µµ·ç
  • base umpire
    ´©½É
  • data base
    µ¥ÀÌÅͺ£À̽º(ÀüÀÚ°è»ê±â¿ë Á¤º¸ÀÇ ÃàÀû ¹× ÀÌ Á¤º¸ÀÇ Á¦°ø ¼­ºñ½º)
  • data base management system
    (Àü»ê)µ¥ÀÌÅͺ£À̽º °ü¸® ½Ã½ºÅÛ(¾à DBMS)
  • first base
    1·ç;1·çÀÇ À§Ä¡(¼öºñ)
  • first base
    ÀÏ·ç¼ö
  • forward base
    ÀüÁø±âÁö
  • free base
    ÇÁ¸® º£À̽º(ÄÚÄ«Àΰú ¿¡Å׸£ÀÇ È¥ÇÕ¹°)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á